News Conference News TCT 2025 What Makes MedTech Great—or Not—and Envisioning Its Future Caitlin E. Cox November 04, 2025
Presentation TCT 2025 University of Pennsylvania's Hypertension Program Presenter: Raymond R. Townsend October 27, 2025
News Conference News TCT 2023 RADIANCE: 'Modest' Renal Denervation Effect Remains at 6 Months Todd Neale October 31, 2023
News Conference News TCT 2022 Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances Caitlin E. Cox September 19, 2022
News Conference News TCT 2022 Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL Yael L. Maxwell September 19, 2022
News Conference News TCT 2022 Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus Yael L. Maxwell September 16, 2022
News Conference News TCT 2020 Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up Michael O'Riordan October 23, 2020
News Conference News TCT 2020 Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2 Michael O'Riordan October 15, 2020
News Conference News TCT 2018 Higher Risk of Rehospitalization, Mortality in TAVR Patients With Severe Device Mismatch Lucy Hicks September 26, 2018
News Conference News TCT 2017 Experts Debate: Should Cerebral Protection Be Used for All TAVRs? Todd Neale November 09, 2017
News Conference News TCT 2016 Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making Yael L. Maxwell November 02, 2016
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015
News Features TCT 2014 Thoughtful Insights at TCT: Many Questions Remain Around Treatment of Valvular Disease Todd Neale October 24, 2014
News Conference News TCT 2013 Novel Device Demonstrates Promise for Percutaneous PDA Closure in Children October 29, 2013